APOE protects against severe infection with Mycobacterium tuberculosis by restraining production of neutrophil extracellular traps
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1013267 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Dong Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America. Hauptthemen laut MEDLINE: Neutrophils, Mycobacterium tuberculosis, Extracellular Traps, Apolipoproteins E. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Mice lacking apolipoprotein E (APOE, Apoe -/- mice) on a high cholesterol (HC) diet are highly susceptible to infection with Mycobacterium tuberculosis (Mtb) but the underlying immune dysregulation has been unclear. While neutrophils are often the predominant cell type in the lungs of humans with severe tuberculosis (TB), they are relatively scarce in the lungs of some strains of mice that are used to study the disease. The neutrophil levels in the lungs of Mtb-infected Apoe -/- HC mice are very high, and thus studies in this model offer the opportunity to examine the role of specific neutrophil functions in the pathology of severe TB. We determined that depleting neutrophils, depleting plasmacytoid dendritic cells (pDCs), or blocking type I interferon signaling improved the outcome of TB in Apoe -/- HC mice. We also demonstrated that blocking the activation of peptidylarginine deiminase 4 (PAD4), an enzyme critical to NET formation, leads to fewer NETs in the lungs and dramatically improves the outcome of TB in Apoe -/- HC mice without affecting the number of neutrophils in the lung. We found that the transcriptional profile of neutrophils in Mtb-infected Apoe -/- HC mice is biased towards a state that resembles the “N2” phenotype that has been defined in cancer models and has been implicated in matrix degradation and tissue destruction. Our observations strongly suggest that the state of the neutrophil when it encounters the Mtb-infected lung is one of the main drivers of severe disease and implies that targeted interventions that alter specific states or functions, such as the production of NETs, may improve outcome while preserving sufficient capacity for host-defense.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
- Department of Pediatrics, University of Washington, Seattle, Washington, United States of America.
- Department of Immunology, University of Washington, Seattle, Washington, United States of America.
- Virginia Mason Franciscan Health, Seattle, Washington, United States of America.
ORCID-Profile: Alan H Diercks, Elizabeth S Gold
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Liu, D., Mai, D., Jahn, A. N., Murray, T. A., Aitchison, J. D., Gern, B. H., Urdahl, K. B., Aderem, A., Diercks, A. H., & Gold, E. S. (2025). APOE protects against severe infection with Mycobacterium tuberculosis by restraining production of neutrophil extracellular traps. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013267
Vancouver
Liu D, Mai D, Jahn AN, Murray TA, Aitchison JD, Gern BH, et al. APOE protects against severe infection with Mycobacterium tuberculosis by restraining production of neutrophil extracellular traps. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013267
BibTeX
@article{Liu2025,
author = {Liu, Dong and Mai, Dat and Jahn, Ana N and Murray, Tara A and Aitchison, John D and Gern, Benjamin H and Urdahl, Kevin B and Aderem, Alan and Diercks, Alan H and Gold, Elizabeth S},
title = {APOE protects against severe infection with Mycobacterium tuberculosis by restraining production of neutrophil extracellular traps},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1013267}
}
EUVIMED